Additional file 1 of Metagenomic analysis reveals differences in the co-occurrence and abundance of viral species in SARS-CoV-2 patients with different severity of disease

Additional file 1: Table S1. Patients included in the study. Information of samples included in study, sample ID, age, and sex of patients, place of collection, date of sample and start of the symptoms, clinical status, comorbidities, sample type, and diagnostic test for other respiratory viruses if performed. Table S2. General sequencing data and SARS-CoV-2 sequenced genome characteristics. Number of reads (original total reads, filtered reads, SARS-CoV-2-specific reads, reads used for metagenomic analysis) and results of SARS-CoV-2 genome sequencing. Table S3. Respiratory viruses found in SARS-CoV-2 positive samples. List of samples with homologs to other (non-SARS-CoV-2) human respiratory viruses. Table S4. Other human (non-respiratory) viruses, found in SARS-CoV-2 positive samples. List of samples with homologs to other non-respiratory human viruses. Table S5. Viruses of other vertebrates found in SARS-CoV-2 infected patients. Contains list of samples with homologs to viruses of other vertebrate species found in SARS-CoV-2 infected patients. Table S6. Non-vertebrate viruses found in SARS-CoV-2 infected persons. Contains list of samples with homologs to non-vertebrate viruses. Table S7. Non-SARS-CoV-2 viruses with > 25% genome coverage. Contains list of viruses, where more than 25% genome was sequenced, from those found in SARS-CoV-2 positive samples.